Evidence map›Paper›PMID 18355636›Full record

ArticleBrain research bulletin2008

Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice.

Christopher D Toscano, Yumi Ueda, York A Tomita, Stefano Vicini, Francesca Bosetti

Open access · greenAbstract read
In one paragraph

Article in Brain research bulletin, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2010
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Christopher D ToscanoBrain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, 9 Memorial Drive, Bethesda, MD 20892, USA.
Yumi Ueda
York A Tomita
Stefano Vicini
Francesca Bosetti
Georgetown University · USGeorgetown University Medical Center · USInstitute on Aging · US

Funding

GABA channels and dopamine in striatumR01MH064797 · NIMH · GEORGETOWN UNIVERSITY · PI VICINI, STEFANO · 2003 to 2014
$3.4M
Role of cyclooxygenases in excitotoxic brain injuryZ01AG000427 · NIA · NATIONAL INSTITUTE ON AGING · PI BOSETTI, FRANCESCA · 2007 to 2008
$421k
Study of brain arachidonic acid metabolism using knockout miceZ01AG000423 · NIA · AGING · PI BOSETTI, FRANCESCA · 2004 to 2007
$102k
Intramural NIH HHS NIH0011410670Intramural NIH HHS Z01 AG000423Intramural NIH HHS Z01 AG000427NIMH NIH HHS MH 64797
6 · The paper itself

Abstract

Excitotoxicity involves over activation of brain excitatory glutamate receptors and has been implicated in neurological, neurodegenerative and neuropsychiatric diseases. Metabolism of arachidonic acid (AA) through the phospholipase A(2) (PLA(2))/prostaglandin-endoperoxide synthase (PTGS) pathway is increased after excitotoxic stimulation. However, the individual roles of the PTGS isoforms in this process are not well established. We assessed the role of the PTGS isoforms in the process of excitotoxicity by exposing mice deficient in either PTGS-1 (PTGS-1(-/-)) or PTGS-2 (PTGS-2(-/-)) to the prototypic excitotoxin, kainic acid (KA). Seizure intensity and neuronal damage were significantly elevated in KA-exposed PTGS-2(-/-), but not in PTGS-1(-/-), mice. The increased susceptibility was not associated with an alteration in KA receptor binding activity or mediated through the CB1 endocannabinoid receptor. The frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) was decreased in the CA1 pyramidal neurons of PTGS-2(-/-) mice, suggesting an alteration of GABAergic function. In wild-type mice, six weeks treatment with the PTGS-2 selective inhibitor celecoxib recapitulated the increased susceptibility to KA-induced excitotoxicity observed in PTGS-2(-/-) mice, further supporting the role of PTGS-2 in the excitotoxic process. The increased susceptibility to KA was also associated with decreased brain levels of PGE(2), a biomarker of PTGS-2 activity. Our results suggest that PTGS-2 activity and its specific products may modulate neuronal excitability by affecting GABAergic neurotransmission. Further, inhibition of PTGS-2, but not PTGS-1, may increase the susceptibility to seizures.

Indexed as

Kainic AcidAnalysis of VarianceAnimalsAutoradiographyCelecoxibChromatography, High Pressure LiquidCyclooxygenase 1Cyclooxygenase 2Enzyme-Linked Immunosorbent Assaygamma-Aminobutyric AcidHippocampusMaleMembrane PotentialsMembrane ProteinsMiceMice, KnockoutAM 251CelecoxibCyclooxygenase 1Cyclooxygenase 2gamma-Aminobutyric AcidKainic AcidMembrane ProteinsPiperidinesPtgs1 protein, mousePtgs2 protein, mousePyrazolesSulfonamides

Identifiers

PMID18355636
PMCPMC2423277
OpenAlexW2055435759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.